Read Contract Pharma - "What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?" Published on June 22, 2023 Bobby Sheng sheds some light on the three main trends impacting CDMOs in 2023 - and potentially for many years ahead. One such trend is an increased demand for the production of novel biologics. The rising need for biologics means more pressure on the industry to bring these...
Press Mentions
Bora Pharmaceuticals Featured in Biopharma Reporter – How Bora is moving into biologics and attempting to crack North America
In this article, Bora discusses its expansion efforts and plans to provide services in the United States. In the large molecule space, Bora offers comprehensive services from the development of mammalian cell lines through cGMP production of drug substance. Read the article
Bora Pharmaceuticals Featured in Contract Pharma – Extrusion-Spheronization Delivery in OSD Manufacturing
Contract Pharma features this engaging article: "Extrusion-Spheronization in OSD Manufacturing. How extrusion-spheronization excels delivering controlled and modified release dose forms." Published on February 21, 2023Contract Pharma In this article Bora explores delivery solutions enabled by the E-S manufacturing process and improved modified release dosage forms as well as improved patient...
Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch
Read Pharma Manufacturing's feature article entitled "Built to Thrive: Three CDMOs that set themselves up to flourish" Published on February 7, 2023 Thank you Pharma Manufacturing and author Karen Longhauser Pharma Manufacturing's feature article positions Bora as one of three fast growing CDMOs to watch. In their interview with Bora CEO, Bobby Sheng, the author acknowledges Bora's values...